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Abstract 
 
Optical coherence tomography (OCT) has recently been demonstrated to measure the film 
coating thickness of pharmaceutical tablets and pellets directly. The results enable the analysis 
of inter- and intra-tablet coating variability at an off-line and in-line setting. To date, only a few 
coating formulations have been tried and there is very little information on the applicability of 
OCT to other coatings. As it is well documented that optical methods including OCT are prone 
to scattering leading to limited penetration, some pharmaceutical coatings may not be 
measurable altogether. This study presents OCT measurements of 22 different common 
coatings for the assessment of OCT applicability.  
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1. Introduction 
 
Film coatings serve the very purpose of achieving colour uniformity, light protection, and taste 
masking. Coatings are additionally used to modify the drug release or to incorporate an active 
pharmaceutical ingredient in the formulation. Coating quality can be studied either by numerical 
modelling [1] or by the aid of process analysers. Various process analytical technology (PAT) 
approaches have been demonstrated for characterising pharmaceutical coating, which include 
NIR and Raman spectroscopy [2-4], nuclear magnetic resonance imaging [5], terahertz pulsed 
imaging (TPI) [6-8] and optical coherence tomography (OCT) [9-15]. Amongst these methods, 
TPI and OCT are attractive because they offer a direct, calibration-free coating thickness 
measurement, where the only unknown is the coating refractive index that can be obtained as a 
one-off measurement with terahertz time-domain spectroscopy and spectroscopic ellipsometry, 
respectively. Comparing the two, TPI has limited resolution (i.e., a lateral spatial of 200 µm and 
axial (depth) resolution of 2 µm for coating thickness greater than 30-40 µm) and requires 
relatively long measurement times (in the range of 8 ms). OCT in contrast, can achieve sub-µm 
resolutions for coating thickness greater than 10 µm and exploits an µs acquisition time leading 
to information on both inter-tablet and intra-tablet coating variation. Specifically, OCT has been 
demonstrated in an off-line [9-11] and in-line setting for characterising pellets [12, 13] and 
tablets [14, 15]. However, OCT has limited penetration depth than TPI, and in some cases fails 
to image through coatings altogether. This limitation originates from a similar refractive index 
between the tablet core and coating leading to weaker reflections, and/or pronounced scattering 
encountered as the optical beam penetrates into the sample, resulting in substantial signal 
attenuation. These effects ultimately limit the resolvable coating thickness. There is currently 
very little information available in the literature on what coating materials can or cannot be 
imaged through using OCT technology. This study therefore aims to examine the transparency 
of a range of coating formulations for OCT measurement at 840 nm.  
 
 
2. Materials and Methods 
 
2.1 Tablet Production 
The samples used in the present work comprise 22 randomly selected tablets from 22 different 
batches where a different coating formulation was used for each of the batches. The coating 
product name, the corresponding alias and photographs of the tablets are shown in Table 1. 
Coating materials were applied to bi-convex shaped tablet cores that contained 50% lactose 
monohydrate and 50% microcrystalline cellulose.  Film coating was performed with a 15” fully 
perforated Labcoat IIX (O’Hara Technologies Inc., Canada) equipped with one spray nozzle 
(970 Düsen-Schlick GmbH, Untersiemau, Germany). The coating pan has a diameter of 380 
mm and a full volume of 4.5 L enabling a batch size of 500 g. Average thickness, diameter and 
weight of the tablet cores (n=6) was 4.079 ± 0.018 mm, 10.069 ± 0.005 mm and 321 ± 3 mg, 
respectively. For measurement comparisons, one side of the tablets was marked by a scratch 
mark to serve as a datum. Film coating thickness was estimated by measuring the physical 
dimensions of coated tablets with a micrometre gauge and subtracting it away from the average 
core thickness, assuming no dimensional changes to the cores in coating. 
 
2.2 Spectral-domain optical coherence tomographic measurements 
An in-house fiber based spectral-domain OCT system [16] was developed for B-scan 
measurements of the coated tablets. As shown in Fig. 1, a super-luminescent diode (EXALOS 
AG, Schlieren, Switzerland), centred at a wavelength of 840 nm with a full width at half 
maximum (FWHM) bandwidth of 55 nm was used as the light source. The light source provided 
a theoretical axial resolution of 5.7 µm in air. The collimated light beam was firstly coupled into 
the input port of a 2 x 2 wideband single mode fiber coupler using a collimator. The light beam 
was subsequently split (50:50) into a reference and a probe beam. The reference beam was 
collimated by an adjustable collimator (CFC-2X-B, Thorlabs Inc., USA) and reflected by a 
reference mirror. The probe beam was focused onto the tablet surface by another identical 
adjustable collimator. The focal length was 7 mm, which lead to a lateral resolution of 20 µm 
and a depth of field of 734 µm. The back-scattered probe beam interfered with the reflected 
reference beam at the output port of the fiber coupler. The interferogram was collected by a high 
resolution spectrometer (Wasatch Photonics Inc., Logan, Utah) consisting of 2048 pixels linear 
array CCD camera. In order to obtain a B-scan (cross-sectional image) across the tablet 
surface, a translation stage was used to move the tablet sample at a velocity of 1 mm/s by a 
motorised stage. The spectrometer was set to acquire a spectrum every 6 ms with an exposure 
time of 90 µs. In total, one thousand A-scans, which covered a length of 6 mm with an 
equivalent step size of 6 µm, were acquired for each tablet to generate a B-scan. The measured 
optical spot size on the tablet surface was approximately 20 µm. Measurements were performed 
perpendicular to the overall tablet surface plane at the tablet centre as opposed to being 
perpendicular to the tablets’ curved surface [6, 7]. As such, only the coating thickness at the 
tablet central region can be accurately measured unless the tablet curvature is accounted for 
[17]. The coating thickness is proportional to the separation between adjacent reflection peaks 
in an A-scan and is determined using d = Δtc/(2n), where d is the coating thickness, c is the 
speed of light, Δt is the peak separation, and n is the coating refractive index. 
 
2.3 X-ray computed microtomography 
X-ray computed microtomography (XµCT) measurement was performed on a Skyscan 1172 
(Bruker, Kontich, Belgium, control software: Skyscan1172 XµCT Control Program v1.5). 
Reconstruction was performed using the program NRecon (Bruker, v1.6.9.8) on a single PC 
using GPU accelerated reconstruction (Windows 7 64-bit workstation, 2 Intel Xeon X5647 with 4 
cores each, 48 GB RAM, NVIDIA Quadro 4000 with 256 cores) yielding 3D data with an 
isotropic voxel size of 0.95 µm. The data acquisition time was 4 hours and the image 
reconstruction took 0.5 h size for 433 slices of 1116 x 1116 pixels.  
 
 
3. Results and Discussions 
 
Figure 2 shows the acquired B-scans of the 22 coated tablets. Evidently, the coating–core 
interface for coatings 1, 2, 7, 8, 13 and 18 can be visibly observed. The level of contrast 
between the air-coating and coating-core interface in coatings 1, 4 and 13 may be enhanced 
with signal denoising [16]. It should be noted that in order to quantify the absolute coating 
thickness, a clear observation of the coating-core interface and knowledge of the coating 
refractive index is required [16, 17]. As refractive index remains unknown in this study, coating 
thickness was not determined but instead, estimated using a micrometre gauge. As a quick 
check, we measured coating 9 using XµCT, sub-volume shown in Figure S1, that yielded a 
thickness of 51.0 ± 6.2 µm (n = 10) in agreement with the estimated thickness of 59 ± 10 µm. 
No thickness information could be derived with OCT in this instance due to an absence of the 
coating-core interface. Closer inspection of Figure S1 also shows that some of the coating has 
fused into the tablet core [18,19], which would have caused a gradual refractive index change 
leading to low contrast in OCT measurement. To better isolate the causes behind OCT 
opaqueness at 840 nm, the coating compositions for the respective coatings are listed in Table 
2.  In coating compositions without pigments or colorants, generally the coating-core interface in 
B-scans is visible. Coatings 1 and 3, however, are notable exceptions because of the additional 
lactose and polydextrose, which may have increased scattering and/or reduced the refractive 
index contrast between the core and coating as the core also contained 50% lactose 
monohydrate. This would then reduce the reflected signal intensity from the coating-core 
interface, resulting in no clear observation of the coating-core interface on the B-scan. 
Assuming negligible optical absorption in the polymer binder [20], for compositions containing 
pigments, in particular, titanium dioxide, the coating-core interface is not visible at all. This is 
due to the pigment particle size and a relatively high value of the effective refractive index that in 
turn, increases reflection at the air-coating interface meaning that only a fraction of incidence 
beam can actually penetrate into the coating [20]. As the remaining beam travels through into 
the coating, more scattering is encountered leading to a further signal reduction for 
measurement. The scattering effect for yellow iron oxide compared to titanium dioxide is 
generally weaker at near-infrared wavelengths [21]. Despite this, coating 9 is still opaque to 
OCT because of the gradual refractive index change encountered because the coating 
dispersion has penetrated into the core material [18,19]. On the contrary, 3% weight gain red 
coating (coating 18), is transparent to OCT largely due to a comparatively larger difference 
between the coating and core refractive index in spite of the increased air-coating reflection 
from the similar coloured coating to the incident beam [22]. For another red coating (coating 20), 
the coating-core interface is not visible due to the titanium dioxide used in a comparatively 
thicker coating (10% weight gain). Finally, it is interesting to note that where the coating 
contains only talc and dye in the colourant as in the case of coating 13, the coating-core 
interface is marginally visible in the OCT measurements.  
 
4. Conclusion 
 
With the emergence of OCT for the non-destructive evaluation of pharmaceutical coatings, it is 
important to know the limitations of the technique. We have presented OCT measurements for a 
range of pigments and formulations based on a popular immediate release coating platform 
used in the pharmaceutical industry today. Our findings show that coating transparency for OCT 
measurement ultimately depends on the pigment type, coating formulation and the tablet core 
as well as the coating process itself. Our findings further show that where the coating material 
contains titanium dioxide, either alone or together with other pigments, OCT measurement 
becomes adversely affected by scattering resulting in a blurred coating-core interface that 
makes coating thickness quantification impossible. For coatings without titanium dioxide, 
coating transparency is not always guaranteed. In order to precisely explain our measurements, 
mechanistic modelling could be applied. We therefore envision that OCT might be best suited 
for PAT applications of functional polymeric coatings, and in particular for multiparticulates 
where high pigmentations can be avoided [10-15, 23]. For coatings on tablets where pigments 
cannot be avoided, TPI is a proven alternative for coating thickness greater than 30-40 µm 
[6,24]. 
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Figure 1 - Schematic of an in-house SD-OCT system with a tablet placed in the perforated 
coating pan. SLD - superluminescent diode, RM – reference mirror, C1 and C2 – adjustable 
collimators 
Figure 2 – B-scans of the coated tablets coated where the air-coating interface can be observed 
and the coating-core interface is only visible for only coatings 1, 2, 7, 8, 13 and 18. 
Table 1 – Images of the tablets coated with the respective coating product and the 
corresponding alias.  
Table 2 – Coating compositions of the coating aliases with the highlighted rows corresponding 
to OCT transparency. The weight and tablet thickness were measured of 6 tablets per batch. 
The coating thickness and weight gain were calculated from the average weight and tablet 
thickness measurements of each batch and the tablet core. The standard deviation was 
calculated by applying the error propagation law. HPMC - hydroxypropyl methylcellulose, PEG - 
polyethylene glycol, PVA - poly(vinyl alcohol), CMC - carboxymethyl cellulose, SLS - sodium 
lauryl sulfate, HPC - hydroxypropyl cellulose. 
Figure S1 – Renderings of a sub-volume from XµCT data of a tablet with coating 9 applied. The 
coating material (yellow) and the tablet core (red) are shown in a), whereas b) depicts only the 
coating material. 
 
